Bangladesh version of ibrutinib price overview
Ibrutinib, a targeted drug targeting B cell malignancies, has achieved remarkable results in the treatment of chronic lymphocytic leukemia and other diseases by precisely intervening in B cell receptor signaling. In view of the high cost of the original drug, many pharmaceutical companies in Bangladesh have launched generic versions of ibrutinib to benefit more patients. The following is an overview of the price of ibrutinib in Bangladesh for the reference of patients.
1. Price and specifications
1. Bangladesh Isida Pharmaceutical: its productIbrucent, the specification is 140mg*90 tablets, and the price range is about more than 1,000 yuan.
2. Bangladesh Beacon Pharmaceutical: LaunchedIbrutix, with a specification of 140mg*120 tablets and a slightly higher price, about more than 4,000 yuan.
3. Bangladesh Ziskar Pharmaceuticals: Its brandBrutini has the same specification of 140mg*120 capsules and the price is relatively affordable, about more than 2,000 yuan.
4. Bangladesh Everest Pharmaceuticals: ProvidesIbruxen, specification: 140mg*120 tablets, price is similar to Brutini, about 2,000 yuan.
5. Bangladesh Yaopin International Pharmaceutical: ItsBUTINIB product has a specification of 140mg*112 capsules, and the price is also within the range of more than 2,000 yuan.
2. Purchase instructions
1. The above prices are for reference only. The actual price may fluctuate due to factors such as region, pharmacy, purchase time, etc. Patients are asked to make reasonable choices based on their own financial situation and needs.
2. You need to be cautious when purchasing medicines overseas. It is recommended to choose formal channels to ensure the quality and safety of medicines.
3. Before purchasing, patients are advised to consult a professional doctor or pharmacist to ensure that ibrutinib is suitable for your condition.
In summary, the diverse choices of the Bangladeshi version of ibrutinib provide patients with more possibilities. When purchasing, patients are asked to comprehensively consider specifications, price, purchasing channels and other factors to make the decision that best suits them.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)